Rolando Sousa
Neurology with Special Qualifications in Child Neurology · Hackensack, NJNPI 1144277211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $605 and has fallen 87.1% since, to $78 in 2025.
Across 95 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$374
- Supernus Pharmaceuticals, Inc.$365
- Sunovion Pharmaceuticals Inc.$258
- SK Life Science, Inc.$162
- Neurelis, Inc.$77
- UCB, Inc.$47
- plus $344 from 13 others
What the payments were for
- Food & beverage$1,624100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 13 | $374 |
| Supernus Pharmaceuticals, Inc. | 18 | $365 |
| Sunovion Pharmaceuticals Inc. | 22 | $258 |
| SK Life Science, Inc. | 9 | $162 |
| Neurelis, Inc. | 5 | $77 |
| UCB, Inc. | 3 | $47 |
| Adlon Therapeutics L.p. | 3 | $46 |
| Aquestive Therapeutics, Inc. | 3 | $43 |
| Aprecia Pharmaceuticals, LLC | 3 | $43 |
| Livanova USA, Inc. | 3 | $41 |
| Greenwich Biosciences, Inc. | 3 | $37 |
| Corium, LLC | 1 | $26 |
| PTC Therapeutics, Inc. | 2 | $24 |
| Biomarin Pharmaceutical Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| Amgen | 1 | $18 |
| Tris Pharma Inc | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 2 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,626 in reported general payments places this provider in the 70th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Other neurology with special qualifications in child neurology in Hackensack
- Juliann PaolicchiHackensack$80K
- Sara RubensteinHackensack$7K
- Michael KatzHackensack$2K
- Celine LeungHackensack$1K
- Yelena RoshchinaHackensack$313
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Carlos LastraNew Brunswick$5K
- Jacqueline RomeroMarlboro$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.